Navidea Biopharmaceuticals, Inc.
OTC: NAVB0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Craig A. Dais CPA
- Employees
- 11
- Headquarters
- Dublin, United States
- IPO year
- 1992
- Market cap
- $10.0K
- Website
- https://www.navidea.com
Loading NAVB…
Loading profile data…Frequently asked questions about NAVB
What does Navidea Biopharmaceuticals, Inc. (NAVB) do?
Navidea Biopharmaceuticals, Inc. is a biopharmaceutical firm dedicated to creating and marketing highly specific diagnostic tools that leverage the immune system, as well as therapeutic agents also based on immune principles. Its operations are divided into two primary divisions: Diagnostic Substances and Therapeutic Development Programs. Centra...
Where does NAVB trade?
Navidea Biopharmaceuticals, Inc. (NAVB) trades on the Other OTC.
What sector is NAVB in?
Navidea Biopharmaceuticals, Inc. (NAVB) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Navidea Biopharmaceuticals, Inc.?
Craig A. Dais CPA is the chief executive officer of Navidea Biopharmaceuticals, Inc. (NAVB).
Where is Navidea Biopharmaceuticals, Inc. headquartered?
Navidea Biopharmaceuticals, Inc. is headquartered in United States.
Does NAVB pay a dividend?
Navidea Biopharmaceuticals, Inc. (NAVB) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did NAVB go public?
Navidea Biopharmaceuticals, Inc. (NAVB) completed its initial public offering in 1992.